Patent · US Active

Composition comprising phosphodiesterase type 5 inhibitor for inhibiting apoptosis of nerve cells

US10064865B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 28, 2017
Grant dateSep 4, 2018
Priority date
Expiry dateJul 28, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a composition and health functional food for inhibiting apoptosis of cranial nerve cells, and to a method for inhibiting apoptosis, wherein the composition and health functional food comprising a phosphodiesterase type 5 active inhibitor. According to the present invention, the PDE5 inhibitor exhibits a protective effect on nerve cells by inhibiting apoptosis of cranial nerve cells. Thus, the present invention can be effectively used to prevent, alleviate, and treat cranial nerve disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.